BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37682182)

  • 1. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
    Lu H; Lin D
    Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
    Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
    J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined Methylation of
    Zhong Q; Wang Y; Liang C; Wei F; She B
    Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of SHOX2 and RASSF1A DNA methylation had a diagnostic value in pulmonary nodules and early lung cancer.
    Xie B; Dong W; He F; Peng F; Zhang H; Wang W
    Oncology; 2024 Jan; ():. PubMed ID: 38262380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
    Ji XY; Li H; Chen HH; Lin J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Analysis of the
    Zhang N; Liu Z; Li K; Xing X; Long C; Liu F; She B; Che N
    J Oncol; 2023; 2023():5888844. PubMed ID: 36691467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
    Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
    Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation.
    Liu J; Bian T; She B; Liu L; Sun H; Zhang Q; Zhu J; Zhang J; Liu Y
    BMC Cancer; 2024 Mar; 24(1):282. PubMed ID: 38429660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic Potential of
    Gao H; Yang J; He L; Wang W; Liu Y; Hu Y; Ge M; Ding J; Ye Q
    Front Oncol; 2022; 12():849024. PubMed ID: 35837113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion.
    Chen S; Huang K; Zou L; Chen L; Hu P
    BMC Pulm Med; 2023 May; 23(1):160. PubMed ID: 37158875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
    Li N; Zeng Y; Huang J
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.
    Deng Q; Su B; Ji X; Fang Q; Zhou S; Zhou C
    Cancer Biomark; 2020; 27(3):313-323. PubMed ID: 31839603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance Evaluation of
    Shi J; Chen X; Zhang L; Fang X; Liu Y; Zhu X; Zhang H; Fan L; Gu J; Zhang S; She B; Han H; Yi X
    Front Oncol; 2020; 10():565780. PubMed ID: 33425721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.
    Ni S; Ye M; Huang T
    Oncotarget; 2017 Sep; 8(37):61253-61263. PubMed ID: 28977861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer "PERFECT" filter system.
    Li T; Liu Y; Zhang W; Lin L; Zhang J; Xiong Y; Nie L; Liu X; Li H; Wang W
    Theranostics; 2020; 10(14):6517-6529. PubMed ID: 32483467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis.
    Ren M; Wang C; Sheng D; Shi Y; Jin M; Xu S
    Ann Diagn Pathol; 2017 Apr; 27():57-61. PubMed ID: 28325362
    [No Abstract]   [Full Text] [Related]  

  • 18. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
    Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
    Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
    Zeng S; Lin C; Huang Y
    Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive diagnostic scheme of morphological combined molecular methylation under bronchoscopy.
    Zhang J; Huang H; Yu F; Bian Y; Wang R; Liu H; Kang S; She B; Shi Z
    Front Oncol; 2023; 13():1133675. PubMed ID: 37182143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.